WHO suspended hydroxychloroquine tests in treatment of COVID-19

The World Health Organization (WHO) has suspended hydroxychloroquine and chloroquine tests as a cure for coronavirus-induced COVID-19. This was announced by WHO Director-General Tedros Adan Ghebrejesus during a briefing on May,25.

“The Executive Group has temporarily suspended the use of hydroxychloroquine and chloroquine in solidarity trials,” the organization said on its Twitter page.

According to the WHO Director General, May 22 The Lancet published an article on the test of hydroxychlorine and chloroquine against COVID-19, which indicated that patients died more often when using these drugs or mixtures with them.

WHO then assembled an expert group from 10 countries. The experts will analyze all the data and the organization will review the effectiveness of the drug, he explained to Hebraeus.

According to the head of the WHO, these drugs are still considered safe for patients with autoimmune diseases and malaria.

As it was stressed in the WHO on May 20, the effectiveness of antimalarial drug chloroquine to prevent and treat COVID-19 has not been proven. On 19 May, the President of the United States Donald Trump admitted the daily intake of coronavirus hydroxychloroquine prevention. In March, the United States allowed the drug to be used to treat the infection.

“Hydroxychloroquine is an antimalarial agent that causes the death of erythrocytic forms of all types of plasmodium. It has immunodepressive and some anti-inflammatory activity.